Literature DB >> 20728788

Nephrogenic systemic fibrosis and gadolinium-enhanced magnetic resonance imaging: does a US Food and Drug Administration alert influence practice patterns in CKD?

Diego R Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20728788     DOI： 10.1053/j.ajkd.2010.07.001

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  5 in total

1.  Manganese-based MRI contrast agents: past, present and future.

Authors:  Dipanjan Pan; Anne H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Tetrahedron       Date:  2011-11-04       Impact factor: 2.457

2.  Mn porphyrins as novel molecular magnetic resonance imaging contrast agents.

Authors:  Vladimir Mouraviev; Talaignair N Venkatraman; Artak Tovmasyan; Masaki Kimura; Matvey Tsivian; Vladimira Mouravieva; Tom J Polascik; Haichen Wang; Timothy J Amrhein; Ines Batinic-Haberle; Christopher Lascola
Journal:  J Endourol       Date:  2012-10-04       Impact factor: 2.942

3.  Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: PRO.

Authors:  Roger A Rodby
Journal:  Kidney360       Date:  2020-12-03

4.  Direct measurement of the Mn(II) hydration state in metal complexes and metalloproteins through 17O NMR line widths.

Authors:  Eric M Gale; Jiang Zhu; Peter Caravan
Journal:  J Am Chem Soc       Date:  2013-10-24       Impact factor: 15.419

5.  Allergic Interstitial Nephritis Manifesting as a Striated Nephrogram.

Authors:  Irfan Moinuddin; Erika Bracamonte; Bijin Thajudeen; Amy Sussman; Machaiah Madhrira; James Costello
Journal:  Case Rep Med       Date:  2015-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.